Outsourcing in Clinical Trials Texas 2022
TEXAS – WE ARE BACK!
The event which provides a platform for trial sponsors and solution providers in Texas to refine their outsourcing strategy, is back for 2022!
Arena International is thrilled to announce that the Outsourcing in Clinical Trials Texas show is coming back to Houston in December. The OCT Texas event was a huge hit when it launched in 2019 and continues to be a unique platform for the vibrant biopharmaceutical cluster in the region to network and collaborate to refine their outsourcing strategies.
The conference is tailor-made to address the concerns of trial sponsors based in Texas who are conducting clinical trials at a local and global level. With a content-driven agenda, interactive networking sessions and a host of innovative service providers, the conference promises to help attendees find the solutions to their most pressing trial challenges.
Register now for your place the OCT Texas event on December 7-8th !
What to Expect for 2022?
The Outsourcing in Clinical Trials Texas event aims to be a solution-driven conference that allows Clinical Operations professionals to network with innovative vendors, hear cutting-edge content, and participate in interactive discussions.
This year, expect to hear from industry leaders learn about future trends, and gain the most up-to-date information on new and upcoming disruptors.
Attendees to meet each year
Exhibitors to meet each year
Attendees at Director+ level
This is an exceptional networking opportunity for industry accelerators in the Texan clinical trial space to meet their peers, uncover fresh insight into common challenges and engage with solution providers
Join like-minded peers to learn new perspectives and case studies on clinical trial development through a series of presentations, panel discussions, interactive round-tables and workshops
The conference discusses the vital connections between process, tools and techniques to manage change. The exhibition space will feature best in class solution providers to deliver improvement in clinical trial development
Translational Drug Development (TD2) is a world-class oncology drug development organization specializing in the development of new oncology medicines. TD2 offers fully integrated precision oncology clinical development solutions that combine the highest standards in clinical trials management, disruptive imaging, biomarker strategies, and unparalleled access to real-time patient data.